RefE-497

Entered

Figures3 min · 507 words

Working paper

Allianz Misses EPS Estimate by $0.10 as Revenue Tops $49B

Allianz posted Q2 EPS of $0.88 versus $0.98 expected, a $0.10 miss, while revenue of $49.14 billion beat the $47 billion consensus; shares opened near 52-week highs.

Exhibit AAllianz (OTCMKTS:ALIZY) Posts Quarterly Earnings Results, Misses Estimates By $0.10 EPS
Allianz (OTCMKTS:ALIZY) Posts Quarterly Earnings Results, Misses Estimates By $0.10 EPS — 652234 / pixabay

Allianz (OTCMKTS: ALIZY) reported quarterly earnings of $0.88 per share on Thursday, missing the consensus estimate of $0.98 by $0.10, according to Zacks. The bottom-line miss sits next to a clear top-line beat: revenue came in at $49.14 billion against analyst expectations of $47 billion.

That's a roughly $2.1 billion revenue surplus paired with a 10-cent earnings shortfall. For a company of Allianz's scale, the combination points to costs and claims absorbing more of the sales than analysts modeled. Profitability metrics stayed healthy but not exceptional: a net margin (the share of revenue left as profit) of 6.31% and a return on equity (profit generated per dollar of shareholder capital) of 18.33%.

The plain read: Allianz sold more than expected and kept less of it.

Where does the stock stand after the print?

ALIZY opened at $52.04 on Friday, trading close to its fifty-two week high of $52.82 and far above its low of $39.44. The shares have been grinding higher for months:

  • 50-day moving average: $49.22
  • 200-day moving average: $46.57
  • Market capitalization: $197.97 billion

Valuation tells a measured story. The stock trades at a price-to-earnings ratio of 14.39, a P/E/G ratio (price-to-earnings adjusted for growth) of 2.30, and carries a beta (volatility relative to the broader market) of 0.66 — low by any standard, typical of a large European insurer.

In short, the market hasn't punished the miss; the stock sits within a dollar of its yearly peak.

What are analysts saying?

Royal Bank of Canada reaffirmed a "sector perform" rating on Allianz in a research report dated Monday, August 10. The broader analyst picture is balanced rather than bullish:

  • Two analysts rate the stock a Buy
  • Two analysts rate it a Hold
  • MarketBeat calculates an average rating of "Moderate Buy"

No analyst in the tracked group has issued a Sell. The consensus posture — positive but restrained — matches the numbers: steady margins, low volatility, an earnings bump that's more blemish than wound.

Who is Allianz, in brief?

Allianz SE is a global insurance and financial services company founded in Berlin in 1890 and headquartered in Munich, Germany. It serves individuals, businesses and institutional clients worldwide. Its insurance operations span property and casualty coverage, life insurance, health insurance and related services, addressing risks from personal and commercial property to health, retirement and employee benefits.

Beyond underwriting, Allianz runs investment and asset management businesses, including Allianz Global Investors and PIMCO — the latter being one of the largest bond managers in the world. That mix gives the group earnings streams from both insurance premiums and fee-based asset management, which explains the stability reflected in its 0.66 beta.

The takeaway for finance desks: a $0.10 EPS miss on a $198 billion insurer with an 18.33% return on equity is noise, not signal — and the market, keeping the stock near $52.82 highs, appears to agree.

Audit trail

  1. Allianz reported quarterly EPS of $0.88 vs. $0.98 consensus, a $0.10 miss.
  2. Quarterly revenue was $49.14 billion vs. $47 billion expected.
  3. Net margin was 6.31%; return on equity was 18.33%.
  4. ALIZY opened Friday at $52.04, near its 52-week high of $52.82; market cap $197.97 billion.
  5. RBC reaffirmed 'sector perform' on August 10; consensus rating is Moderate Buy (2 Buy, 2 Hold).

via dailypolitical.com (Source)

Filed under

  • allianz
  • eps
  • q3-earnings
  • insurance
  • analyst-ratings
Share this article:

More from Grace Kim

Grace Kim

Show full bio

Staff writer covering people, launches and day-to-day practice in corporate finance and the leaders who run it at CFO Observer.

232 articles

Cross-references

« Previous articleNext article »